New research at the Lewis Katz School of Medicine at Temple University shows the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.), already shown to be effective for reducing blockages in lung arteries, also reduces blockages in the smaller segmental pulmonary artery branches. The findings are described in JACC: Advances. Riyaz Bashir, MD, FACC, Director of Vascular and Endovascular Medicine at Temple University Hospital, is the co-inventor of the catheter and first author on the new report. ScienceDaily highlighted the news.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH